Allosteric SHP2 Inhibition Increases Apoptotic Dependency on BCL2 and Synergizes with Venetoclax in FLT3- and KIT- Mutant AML https://www.biorxiv.org/content/10.1101/2022.12.01.518665v1?med=mas
Allosteric SHP2 Inhibition Increases Apoptotic Dependency on BCL2 and Synergizes with Venetoclax in FLT3- and KIT- Mutant AML https://www.biorxiv.org/content/10.1101/2022.12.01.518665v1?med=mas